Handelsinvest Investeringsforvaltning Cuts Stock Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Handelsinvest Investeringsforvaltning lowered its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 34.2% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,239 shares of the company’s stock after selling 1,162 shares during the period. Handelsinvest Investeringsforvaltning’s holdings in Acadia Healthcare were worth $177,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in ACHC. State of Michigan Retirement System boosted its stake in Acadia Healthcare by 2.3% during the 1st quarter. State of Michigan Retirement System now owns 22,630 shares of the company’s stock valued at $1,793,000 after purchasing an additional 500 shares during the last quarter. Vaughan Nelson Investment Management L.P. boosted its stake in Acadia Healthcare by 40.6% during the 1st quarter. Vaughan Nelson Investment Management L.P. now owns 436,880 shares of the company’s stock valued at $34,610,000 after purchasing an additional 126,220 shares during the last quarter. Mather Group LLC. purchased a new stake in Acadia Healthcare during the 1st quarter valued at $48,000. Vanguard Group Inc. boosted its stake in Acadia Healthcare by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 8,861,427 shares of the company’s stock valued at $689,065,000 after purchasing an additional 30,296 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its stake in Acadia Healthcare by 5.2% during the 4th quarter. Goldman Sachs Group Inc. now owns 454,793 shares of the company’s stock valued at $35,365,000 after purchasing an additional 22,290 shares during the last quarter.

Analyst Upgrades and Downgrades

ACHC has been the topic of several recent analyst reports. StockNews.com downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Tuesday, May 21st. TD Cowen dropped their price target on Acadia Healthcare from $101.00 to $91.00 and set a “buy” rating on the stock in a research note on Friday, May 17th. Mizuho dropped their price target on Acadia Healthcare from $84.00 to $70.00 and set a “neutral” rating on the stock in a research note on Friday, May 3rd. Bank of America dropped their price target on Acadia Healthcare from $105.00 to $90.00 and set a “buy” rating on the stock in a research note on Thursday, May 2nd. Finally, Cantor Fitzgerald restated a “neutral” rating and issued a $90.00 price target on shares of Acadia Healthcare in a research note on Tuesday. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company. According to MarketBeat, Acadia Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $87.56.

Acadia Healthcare Trading Up 0.9 %

ACHC opened at $66.74 on Thursday. The stock has a 50-day moving average of $68.20 and a 200 day moving average of $75.66. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.63. Acadia Healthcare Company, Inc. has a 12 month low of $62.04 and a 12 month high of $87.77. The firm has a market cap of $6.19 billion, a P/E ratio of -476.68, a P/E/G ratio of 2.03 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share for the quarter, beating the consensus estimate of $0.80 by $0.04. The firm had revenue of $768.10 million during the quarter, compared to the consensus estimate of $779.20 million. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. The company’s revenue was up 9.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.75 earnings per share. As a group, research analysts forecast that Acadia Healthcare Company, Inc. will post 3.52 EPS for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.